United-Guardian, Inc. (UG) — Analysis Summary
United-Guardian, Inc. (UG) has a market cap of $32.16M with year-over-year revenue growth of -13.4%. Net margin stands at 20.0%. The stock trades at a P/E ratio of 13.0.
Key Takeaways
- Revenue changed -13.4% year-over-year
- Net margin of 20.0%
- P/E ratio of 13.0
Compared to other companies in the PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS sector, UG posted revenue growth of -13.4% and trades at a P/E of 13.0.
United-Guardian, Inc. (UG)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.
Sector
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Employees
25
Headquarters
HAUPPAUGE, NY
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.60
Dividend Yield
8.70%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.